is a criteria set known to be noninvasive and proposed as highly specific. Methods: 86 patients (F: 96%, mean age: 51.7±11.8) following up in our clinic with the diagnosis of pSS were enrolled to the study.Expert opinion had been taken as gold standard for pSS diagnosis. Patients were questioned for eye/mouth dryness. Antinuclear antibody (ANA), complement (C3, C4), anti-Ro and anti-La, serum protein electrophoresis, rheumatoid factor (RF), break-up time (BUT) and Schirmer, minor salivary gland biopsy results were analysed cautiously. The aforementioned criteria sets, were implemented to assess the classification. The percentage of exact agreement and Kappa test was calculated. Results: Number of patients classified as pSS according to ACR/SICCA, AECG and M.model criteria were 75 (87%), 63 (73%) and 58 (67%) respectively. 9 patients (10%) did not fulfill any of these 3 criteria but they were diagnosed as pSS according to expert opinion (Image 1). The Kappa test was moderate between the ACR/SICCA and AECG criteria and slightly low between the M.model with the AECG and ACR/SICCA criteria (Table 1) . According to our proposed combination model, number of patients classified as pSS, either AECG or M.model was 74(86%); either AECG or ACR/SICCA model was 76(88%); either ACR/SICCA or M.model was 77 (89.5%) ( Table 2 ). In the triple combination of our model, if all 3 criteria used concomitantly, only 46 (51%) of patients fulfill the criteria simultaneously; however if any of 3 criteria sets used 77 (89.5%) patients fulfill as pSS.
